¾ø¾ÊÇÖ¸Âѳ²¹¦Ð§Ë¥ÍË£¬Ô¾×èÖ¹£¬±ê¼Ç×ÅÅ®ÐÔÉúÖ³¹¦Ð§µÄÖÕÖ¹¡£Ò»Ñùƽ³£À´Ëµ£¬ÕýÖÕÄêËê¹æģͨ³£Îª45ÖÁ55ËêÖ®¼ä£¬ÎÒ¹úÕý³£¸¾Å®¾ø¾Æ½¾ùÄêËêΪ49.5Ëê¡££¼40ËêΪ¹ýÔç¾ø¾£»40-44ËêΪÔç¾ø¾¡£
´ÓΧ¾ø¾ÆÚ×îÏÈ£¬Ëæ×ÅÂÑÅÝÊýÄ¿Öð½¥ïÔÌ£¬´Æ¼¤ËØˮƽҲÖð½¥½µµÍ¡£´Æ¼¤ËØÄܹ»Í¨¹ýÔö½øÄÚƤϵͳѪ¹ÜµÄÊæÕÅ£¬ÒÖÖƶ¯ÂöÖàÑùÓ²»¯µÄ±¬·¢£¬¾ßÓÐÖ÷ÒªµÄÐÄѪ¹Ü±£»¤¹¦Ð§¡£ÒѾø¾Å®ÐÔ±¬·¢ÐÄѪ¹Ü¼²²¡µÄΣº¦ÏÔÖø¸ßÓÚδ¾ø¾Å®ÐÔ¡£Óв¿·ÖÑо¿ÒÔΪÊÇÓÉÓڴƼ¤ËØˮƽµÄȱʧ£¬ÐÄѪ¹ÜϵͳʧȥÁ˴Ƽ¤Ëصı£»¤×÷Óöøµ¼ÖÂÁ˼²²¡µÄ±¬·¢¡£
¸ÃÑо¿ÌáÐÑÁË2¸öÖ÷ÒªµÄ½áÂÛ£º
1. ¾ø¾ÄêËê½ÏÔ磬ÌØÊâÊÇ×ÔÈ»¾ø¾ÄêË꣬Óë½Ï¶ÌµÄ°×ϸ°û¶ËÁ£³¤¶È×ÔÁ¦ÏÔÖøÏà¹Ø¡£
2 .°×ϸ°û¶ËÁ£³¤¶ÈÊÇ×ÔÈ»¾ø¾ÄêËêÓë¹Ú×´¶¯Âö¼²²¡±¬·¢ÂʵÄÖ÷ÒªÖÐÐÄÒòËØ¡£ÌáÇ°Ôç¾ø¾ºÍ¶ËÁ£³¤¶ÈµÍÓÚƽ¾ùˮƽµÄÅ®ÐÔ£¬ÎªÎ£º¦×î¸ßµÄ×é±ð¡£
ÆÊÎöÔµ¹ÊÔÓÉ¿ÉÄÜÊÇÓÉÓÚ£º¶ËÁ£Äܹ»±£»¤»ùÒò×éÎȹÌÐÔ£¬µ«Æ䳤¶È»áÔÚÒ»Á¬µÄϸ°ûÆÆËéÖÐËõ¶Ì¡£Ëæ×ÅÄêËêµÄÔöÌí£¬¶ËÁ£³¤¶È¹ý¶Ì¡¢Ëõ¶ÌËÙÂʹý¿ì£¬µ¼ÖÂÌåϸ°û»ùÒò×é²»Îȹ̵ÈÕ÷Ïó¡£
µ±¶ËÁ£±äµÃºÜÊǶÌʱ£¬DNAËðÉËÐÞ¸´»úÖÆ»áÓÕµ¼Ï¸°ûÐàÂõ£¬µ¼ÖÂÓëÐàÂõÏà¹ØµÄÉø͸±íÐÍ£¬Ôö½øÐÄѪ¹ÜÐàÂõºÍ¼²²¡.
ͨ¹ýÕâ¸öÑо¿£¬ÎÒÃÇ¿ÉÒÔ¿´µ½¾ø¾Óë¶ËÁ£³¤¶ÈÖ®¼äµÄ¹Øϵ£¬ÒÔ¼°ÕâÖÖ¹ØϵÔõÑùÓ°Ïì¹ÚÐIJ¡ÊÂÎñµÄΣº¦¡£¶ËÁ£¼ÓËÙËõ¶Ì¶Ô×ÔÈ»Ôç¾ø¾ÓÐÒò¹û¹Øϵ£¬²¢ÇÒ¶ËÁ£³¤¶ÈÊÇ×ÔÈ»¾ø¾ÄêËêÓë¹Ú×´¶¯Âö¼²²¡±¬·¢ÂʵÄÖ÷ÒªÖÐÐÄÒòËØ¡£Òò´ËÔç¾ø¾Å®ÐÔºÍΧ¾ø¾ÆÚÅ®ÐÔÐèÒª¶Ô¶ËÁ£³¤¶È¾ÙÐа´ÆÚ¼à²â£¬ÒÔÕ¹ÍûDZÔÚµÄÔç¾ø¾ºÍÐÄѪ¹ÜÊÂÎñΣº¦¡£
ÕâЩ·¢Ã÷Òâζ×ÅÔÚÔç¾ø¾µÄ¸¾Å®ÖУ¬Ò»·½Ãæ¿ÉÒÔͨ¹ý÷缯µÄ³õ¼¶Ô¤·À»ñÒ棬ÈçËûÍ¡ÀàÒ©Îï¡¢¼¤ËØÌæ»»ÁÆ·¨£»Ò»·½Ãæ¿ÉÒÔͨ¹ýÕë¶Ô¶ËÁ£µÄ¶¨ÏòÖÎÁÆ£¬°üÀ¨¸Ä±äÉúÑÄ·½·¨¡¢ÒûʳºÍÔ˶¯Ï°¹ß£¬»òÕßʹÓÃÌض¨µÄÒ©ÎïÖÎÁƵȣ¬±ÜÃâ¶ËÁ£³¤¶ÈµÄËõ¶Ì£¬¿ÉÄÜÄܹ»¸ÄÉÆËýÃǵÄÐÄѪ¹Ü¼²²¡µÄ»¼²¡Î£º¦ºÍÔ¤ºó¡£
²Î¿¼ÎÄÏ×:
Schuermans A, Nakao T, Uddin MM, Hornsby W, Ganesh S, Shadyab AH, Liu S, Haring B, Shufelt CL, Taub MA, Mathias RA, Kooperberg C, Reiner AP, Bick AG, Manson JE, Natarajan P, Honigberg MC. Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women. Circ Res. 2023 Aug 18;133(5):376-386.